NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 89,000 shares, a drop of 19.2% from the February 13th total of 110,200 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 234,600 shares, the days-to-cover ratio is currently 0.4 days.

NovaBay Pharmaceuticals Price Performance

NYSEAMERICAN:NBY opened at $0.64 on Tuesday. NovaBay Pharmaceuticals has a 1-year low of $0.36 and a 1-year high of $9.08. The firm has a market capitalization of $2.71 million, a P/E ratio of -0.06 and a beta of 2.82.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.